Merit Medical Systems, Inc manufactures and markets disposable medical devices for interventional, diagnostic, and therapeutic procedures in cardiology, radiology, oncology, critical care, and endoscopy. The company operates through Cardiovascular and Endoscopy segments. It provides peripheral intervention products, including access, angiography, intervention, and drainage and biopsy for diagnosis and treatment of diseases in peripheral vessels and organs; and cardiac intervention products, such as access, angiography, hemostasis, intervention, and electrophysiology and cardiac rhythm management products to treat various heart conditions.
Read More…
Industry, Sector and Symbol
Industry Surgical & medical instruments
Sub-IndustryHealth Care Supplies
SectorMedical
Phone801-253-1600
Debt
Price-To-Earnings
Sales & Book Value
Annual Sales$882.75 million
Profitability
Miscellaneous
Employees5,783
Next Earnings Date10/24/2019 (Estimated)
OptionableOptionable
Merit Medical Systems (NASDAQ:MMSI) Frequently Asked Questions
What is Merit Medical Systems' stock symbol?
Merit Medical Systems trades on the NASDAQ under the ticker symbol "MMSI."
How were Merit Medical Systems' earnings last quarter?
Merit Medical Systems, Inc. (NASDAQ:MMSI) announced its quarterly earnings results on Thursday, July, 25th. The medical instruments supplier reported $0.42 earnings per share for the quarter, missing the consensus estimate of $0.50 by $0.08. The medical instruments supplier had revenue of $255.50 million for the quarter, compared to analysts' expectations of $258.58 million. Merit Medical Systems had a net margin of 4.10% and a return on equity of 10.40%. The firm's revenue was up 13.7% compared to the same quarter last year. During the same quarter in the prior year, the business posted $0.43 earnings per share. View Merit Medical Systems' Earnings History.
When is Merit Medical Systems' next earnings date?
What guidance has Merit Medical Systems issued on next quarter's earnings?
Merit Medical Systems issued an update on its FY19 earnings guidance on Thursday, July, 25th. The company provided earnings per share (EPS) guidance of $1.74-1.97 for the period, compared to the Thomson Reuters consensus estimate of $2.01. The company issued revenue guidance of $1.007-1.029 billion, compared to the consensus revenue estimate of $1.02 billion.
What price target have analysts set for MMSI?
7 equities research analysts have issued 12 month price objectives for Merit Medical Systems' stock. Their forecasts range from $46.00 to $74.00. On average, they anticipate Merit Medical Systems' stock price to reach $61.5714 in the next year. This suggests a possible upside of 79.9% from the stock's current price. View Analyst Price Targets for Merit Medical Systems.
What is the consensus analysts' recommendation for Merit Medical Systems?
7 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Merit Medical Systems in the last year. There are currently 2 hold ratings and 5 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Merit Medical Systems.
What are Wall Street analysts saying about Merit Medical Systems stock?
Here are some recent quotes from research analysts about Merit Medical Systems stock:
- 1. Barrington Research analysts commented, "We are currently modeling non-GAAP EPS of $1.75 on revenue of $1.014 billion in FY/19." (7/26/2019)
- 2. According to Zacks Investment Research, "Shares of Merit Medical outperformed the industry in a year’s time. Significant expansion in adjusted gross margins in recent times buoy optimism in the stock. Robust Cardiovascular unit also encourages. Management is optimistic about Merit Medical’s Becton Dickinson deal that is set for completion at the end of 2019. Cianna Medical and Vascular Insights buyouts continue to contribute to results. Management is optimistic about several new products that are slated for introduction in the second quarter of 2019. However, escalating operating expenses remains a concern for the company. Headwinds like stiff competition and higher consolidation in the healthcare industry add to the woes. Sluggishness in the Custom kits and procedure trays and Embolization devices units is also concern. The stock is overvalued at the moment." (7/1/2019)
- 3. Needham & Company LLC analysts commented, "MMSI’s 1Q19 revenue and EPS beat consensus (due to a lower than expected tax rate). Management reiterated its 2019 revenue and EPS guidance. Organic revenue growth slowed from 4Q18 despite an easier comp. Gross margin expansion was partially offset by higher SG&A but MMSI still delivered 60 bps of Y/Y operating margin improvement. We still believe there are multiple sources of upside to revenue (e.g. BD products are organic, Cianna SCOUT would be incremental) and EPS guidance (e.g. continued margin improvement) and we reiterate our Buy rating." (4/25/2019)
Has Merit Medical Systems been receiving favorable news coverage?
Headlines about MMSI stock have been trending positive recently, InfoTrie Sentiment Analysis reports. InfoTrie identifies negative and positive press coverage by monitoring more than six thousand blog and news sources in real time. The firm ranks coverage of publicly-traded companies on a scale of negative five to five, with scores nearest to five being the most favorable. Merit Medical Systems earned a coverage optimism score of 2.5 on InfoTrie's scale. They also gave media headlines about the medical instruments supplier a news buzz of 6.0 out of 10, indicating that recent press coverage is somewhat likely to have an impact on the company's share price in the near future. View News Stories for Merit Medical Systems.
Who are some of Merit Medical Systems' key competitors?
Some companies that are related to Merit Medical Systems include Hill-Rom (HRC), Haemonetics (HAE), Integra Lifesciences (IART), Globus Medical (GMED), Penumbra (PEN), Tandem Diabetes Care (TNDM), Cantel Medical (CMD), NuVasive (NUVA), ICU Medical (ICUI), Nevro (NVRO), Glaukos (GKOS), Irhythm Technologies (IRTC), Cardiovascular Systems (CSII), Atrion (ATRI) and Silk Road Medical (SILK).
What other stocks do shareholders of Merit Medical Systems own?
Who are Merit Medical Systems' key executives?
Merit Medical Systems' management team includes the folowing people:
- Mr. Fred P. Lampropoulos, Chairman, CEO & Pres (Age 69)
- Mr. Ronald A. Frost, Chief Operating Officer (Age 57)
- Mr. Brian G. Lloyd, Chief Legal Officer & Corp. Sec. (Age 58)
- Mr. Joseph C. Wright, Pres of International Division (Age 49)
- Mr. Raul Parra Jr., CPA, CFO & Treasurer
Who are Merit Medical Systems' major shareholders?
Merit Medical Systems' stock is owned by a number of of institutional and retail investors. Top institutional shareholders include BlackRock Inc. (15.58%), BlackRock Inc. (15.53%), Vanguard Group Inc. (10.06%), Eagle Asset Management Inc. (3.35%), Invesco Ltd. (1.77%) and Jennison Associates LLC (1.70%). Company insiders that own Merit Medical Systems stock include F Ann Millner, Franklin J Miller, Fred P Lampropoulos, Joseph Wright, Justin J Lampropoulos, Kent W Stanger, Michael E Stillabower, Nolan E Karras, Raul Jr Parra and Ronald Frost. View Institutional Ownership Trends for Merit Medical Systems.
Which major investors are selling Merit Medical Systems stock?
MMSI stock was sold by a variety of institutional investors in the last quarter, including Rothschild & Co. Asset Management US Inc., Perceptive Advisors LLC, SG Capital Management LLC, Mackenzie Financial Corp, Mackenzie Financial Corp, Russell Investments Group Ltd., Axiom International Investors LLC DE and Eagle Boston Investment Management Inc.. Company insiders that have sold Merit Medical Systems company stock in the last year include F Ann Millner, Franklin J Miller, Fred P Lampropoulos, Justin J Lampropoulos, Kent W Stanger, Michael E Stillabower, Nolan E Karras, Raul Jr Parra and Ronald Frost. View Insider Buying and Selling for Merit Medical Systems.
Which major investors are buying Merit Medical Systems stock?
MMSI stock was bought by a variety of institutional investors in the last quarter, including Conestoga Capital Advisors LLC, BlackRock Inc., BlackRock Inc., Invesco Ltd., Nuveen Asset Management LLC, Morgan Stanley, Fiera Capital Corp and Landscape Capital Management L.L.C.. View Insider Buying and Selling for Merit Medical Systems.
How do I buy shares of Merit Medical Systems?
Shares of MMSI can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is Merit Medical Systems' stock price today?
One share of MMSI stock can currently be purchased for approximately $34.23.
How big of a company is Merit Medical Systems?
Merit Medical Systems has a market capitalization of $1.89 billion and generates $882.75 million in revenue each year. The medical instruments supplier earns $42.02 million in net income (profit) each year or $1.69 on an earnings per share basis. Merit Medical Systems employs 5,783 workers across the globe.View Additional Information About Merit Medical Systems.
What is Merit Medical Systems' official website?
How can I contact Merit Medical Systems?
Merit Medical Systems' mailing address is 1600 WEST MERIT PARK WAY, SOUTH JORDAN UT, 84095. The medical instruments supplier can be reached via phone at 801-253-1600 or via email at [email protected]
MarketBeat Community Rating for Merit Medical Systems (NASDAQ MMSI)
MarketBeat's community ratings are surveys of what our community members think about Merit Medical Systems and other stocks. Vote "Outperform" if you believe MMSI will outperform the S&P 500 over the long term. Vote "Underperform" if you believe MMSI will underperform the S&P 500 over the long term. You may vote once every thirty days.
